WST Financials
West Pharmaceutical Services Inc - Financial statements & key metrics
Stock Price
$254.34
Market Cap
$18.32B
P/E Ratio
37.5
EPS
$6.79
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.89B
Gross Profit
-
Operating Income
-
Net Income
$492.70M
EPS (Diluted)
$6.69
Balance Sheet Highlights
Total Assets
$3.64B
Total Liabilities
$961.10M
Shareholders Equity
-
Cash & Equivalents
$484.60M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$653.40M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
35.9%
Operating Margin
0.2%
Net Margin
0.2%
ROE
0.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is WST revenue?
WST's most recent quarterly revenue was $2.89B. Annual revenue can be calculated by summing the four most recent quarters.
Is WST profitable?
WST reported a profit of $492.70M in the most recent quarter. The net profit margin is 0.2%.
What is WST market cap?
WST has a market capitalization of $18.32B, making it a large-cap stock.
Does WST have debt?
View WST's balance sheet for debt information.
What is WST cash flow?
Cash flow data is available in the full financial statements.